BridgeMD
New treatment option for Epilepsy
Official title Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
ClinicalTrials.gov ID: NCT06623994
What this study is testing
- What it's testing
- This cluster randomized trial aims to learn about the effectiveness of task-sharing supported by an epilepsy medical records system (EMRS) (hereafter referred to as BEACON) with patient-tracking data in improving treatment adherence and retention in care in people with epilepsy in western Kenya.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 and older
You may be able to join if
- Individuals ≥12 years
- Residents of Busia or Trans Nzoia County
- Diagnosed with possible epilepsy through initial screening and confirmed diagnosis by an epilepsy-trained professional with the BEACON project or...
- Have a diagnosis of epilepsy but are not adherent to antiseizure medication treatment.
You likely can't join if
- Individuals receiving care from a neurosurgeon or neurologist for a serious brain disorder
- Unable or unwilling to provide voluntary informed consent or assent (12-18 years)
The study team makes the final eligibility decision.
Where it's taking place
- Eldoret, Kenya
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Eldoret, Kenya. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.